Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Headquartered in Geneva, Switzerland Alcon Inc. (ALC) researches, develops, manufactures, distributes, and sells a ...

Alcon announced in early August that it has entered into a definitive merger agreement with Staar, under which Alcon will ...

Yunqi Capital Limited (together with its affiliates and the funds it advises, "Yunqi Capital"), an investment management firm and 5.1% shareholder of STAAR Surgical Company ("STAAR" or the "Company") ...

Bausch + Lomb swung to a loss in the latest quarter as a rise in the Canadian eye-health company's income tax provision offset a rise in revenue across its business segments. The company recorded a ...

Dry eye treatments include over-the-counter eye drops and prescription medicines. The AMCP abstract included immunomodulators ...

Principal photography is underway on ‘The Future Is Ours,’ Netflix’s first Latin American adaptation of a Philip K. Dick ...

Millions of contact lens wearers navigating busy schedules and long hours on screens are seeking a balance of comfort and ...

Broadwood Partners, STAAR's largest shareholder, opposes the Alcon merger, citing board conflicts and rushed decision-making.

Bradsher, Broadwood Founder and President, said: "The decision to postpone a shareholder vote on the sale of STAAR to Alcon is the latest in a long string of bad decisions by this Board, which ran a ...

Staar Surgical Co. reported on Oct. 24 that it had adjourned its special meeting of stockholders scheduled in connection with its proposed $1.5 billion sale to Alcon AG in the face of objections from ...

Staar Surgical has adjourned its shareholder vote on Swiss eyecare giant Alcon's $1.5 billion takeover offer until November 6, the company said on Thursday.

The special meeting to vote on the company's $1.5 billion sale to Alcon, originally scheduled for today, has been adjourned ...